10.1007/s40204-019-0115-8

Different zeolite systems for colon cancer therapy: monitoring of ion release, cytotoxicity and drug release behavior

HTML PDF
  • A. G. Abd-Elsatar1,
  • M. M. Farag2,
  • H. F. Youssef*1,
  • S. A. Salih3,
  • M. M. Mounier4,
  • E. El-Meliegy1,
  1. Ceramics, Refractories and Building Materials Department, National Research Centre, Dokki, Cairo, 12622, EG
  2. Glass Research Department, National Research Centre, Dokki, Cairo, 12622, EG
  3. Physical Chemistry, Faculty of Science, Cairo University, Cairo, EG
  4. Pharmacognosy Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, Dokki, Cairo, 12622, EG
Cover Image

Published in Issue 2019-05-20

How to Cite

Abd-Elsatar, A. G., Farag, M. M., Youssef, H. F., Salih, S. A., Mounier, M. M., & El-Meliegy, E. (2019). Different zeolite systems for colon cancer therapy: monitoring of ion release, cytotoxicity and drug release behavior. Progress in Biomaterials, 8(2 (June 2019). https://doi.org/10.1007/s40204-019-0115-8
Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Abstract Three types of oral administrated micronized zeolites [ZSM-5, zeolite A and Faujasite NaX (ZSM-5, ZA and ZX, respectively)] were prepared as anticancer 5-fluorouracil (5-Fu) delivery systems for colon cancer treatment. They were prepared by economically widespread and cheap natural resource, kaolin, at low temperatures, using microwave advanced tool. The obtained powders were characterized by XRD, SEM/EDX and BET; meanwhile, their degradation was investigated in two gastric fluids; FaSSGF (pH 1.6) and FeSSGF (pH 5), through concentration measurement of their solution disintegrated elemental constituents of Na + , Al 3+ and Si 4+ ions. Also, the processes of drug release and mechanism in both solutions were investigated. Moreover, the inhibition action of 5-Fu-free and 5-Fu-conjugated zeolites on colon cancer cells (CaCo-2) was estimated. The results showed that, the prepared zeolites possessed high surface areas of 526, 250, and 578 m 2 /g for ZSM-5, ZA and ZX, respectively. Although, zeolite structures seemed significantly stable, their frameworks seemed more likely reactive with time. The ions and drug release for zeolites occurred in successively two stages and found to be pH dependent, where the drug and zeolite ions were significantly of higher values in the more acidic media of the gastric solution (pH 1.6) than those of the mild acidic one (pH 5). The obtained activity indicated no cytotoxic affinity for all the prepared zeolite types. Accordingly, the synthesized zeolite frameworks are proposed to be of strong potential drug delivery vehicle for the treatment of gastrointestinal cancer. Graphical abstract

Keywords

  • Fluorouracil (5-Fu),
  • Drug delivery,
  • Synthetic zeolites,
  • Simulated gastric fluid,
  • Colon cancer
HTML PDF

References

  1. Absher and Mortara (1980) Effect of silica on the proliferative behavior of human lung fibroblasts (pp. 371-376) https://doi.org/10.1007/BF02618359
  2. Al-Thawabeia and Hodali (2015) Use of zeolite ZSM-5 for loading and release of 5-fluorouracil https://doi.org/10.1155/2015/403597
  3. Banerjee et al. (2017) Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives (pp. 1224-1232) https://doi.org/10.1016/j.drudis.2017.05.006
  4. Beran and Dubsky (1979) Quantum chemical study of the electronic structure of Na-X and Na-Y zeolites (pp. 2538-2544) https://doi.org/10.1021/j100482a023
  5. Bougeard et al. (2000) Vibrational spectra and structure of kaolinite: a computer simulation study (pp. 9210-9217) https://doi.org/10.1021/jp0013255
  6. Chandrasekhar et al. (1997) Brightness improvement studies on ‘kaolin based’zeolite 4A (pp. 221-231) https://doi.org/10.1016/S0169-1317(97)00008-2
  7. Čimek et al. (1997) Dissolution of high-silica zeolites in alkaline solutions II. Dissolution of ‘activated’ silicalite-1 and ZSM-5 with different aluminum content (pp. 159-169) https://doi.org/10.1016/S0927-6513(96)00082-X
  8. Costa and Lobo (2001) Modeling and comparison of dissolution profiles (pp. 123-133) https://doi.org/10.1016/S0928-0987(01)00095-1
  9. Datt et al. (2013) Loading and release of 5-fluorouracil from HY zeolites with varying SiO 2/Al2O3 ratios (pp. 182-187) https://doi.org/10.1016/j.micromeso.2012.09.011
  10. El-Ghannam et al. (2010) A ceramic-based anticancer drug delivery system to treat breast cancer (pp. 2701-2710) https://doi.org/10.1007/s10856-010-4121-6
  11. El-Sherbiny et al. (2005) Preparation, characterization, swelling and in vitro drug release behaviour of poly [N-acryloylglycine-chitosan] interpolymeric pH and thermally-responsive hydrogels (pp. 2584-2591) https://doi.org/10.1016/j.eurpolymj.2005.05.035
  12. First et al. (2011) Computational characterization of zeolite porous networks: an automated approach (pp. 17339-17358) https://doi.org/10.1039/c1cp21731c
  13. Higuchi (1963) Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices (pp. 1145-1149) https://doi.org/10.1002/jps.2600521210
  14. Karavasili et al. (2017) Comparison of different zeolite framework types as carriers for the oral delivery of the poorly soluble drug indomethacin (pp. 76-87) https://doi.org/10.1016/j.ijpharm.2017.05.061
  15. Khodaverdi et al. (2016) Synthetic zeolites as controlled-release delivery systems for anti-inflammatory drugs (pp. 849-857) https://doi.org/10.1111/cbdd.12716
  16. Kralj and Pavelic (2003) Medicine on a small scale: how molecular medicine can benefit from self-assembled and nanostructured materials (pp. 1008-1012) https://doi.org/10.1038/sj.embor.7400017
  17. Kühl et al. (1999) Springer
  18. Kuronen et al. (2000) Effect of the framework charge density on zeolite ion exchange selectivities (pp. 2655-2659) https://doi.org/10.1039/b001353f
  19. Li et al. (2008) Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles https://doi.org/10.1186/1471-2407-8-103
  20. Marques et al. (2011) Simulated biological fluids with possible application in dissolution testing (pp. 15-28) https://doi.org/10.14227/DT180311P15
  21. Mumpton (1999) La roca magica: uses of natural zeolites in agriculture and industry (pp. 3463-3470) https://doi.org/10.1073/pnas.96.7.3463
  22. Munthali et al. (2014) Proton adsorption selectivity of zeolites in aqueous media: effect of Si/Al ratio of zeolites (pp. 20468-20481) https://doi.org/10.3390/molecules191220468
  23. Munthali et al. (2015) Proton adsorption selectivity of zeolites in aqueous media: effect of exchangeable cation species of zeolites (pp. 91-104) https://doi.org/10.3390/environments2010091
  24. Nagy et al. (2011) Silver nanoparticles embedded in zeolite membranes: release of silver ions and mechanism of antibacterial action (pp. 1833-1852)
  25. Pasquino et al. (2016) Rheology-sensitive response of zeolite-supported anti-inflammatory drug systems (pp. 938-944) https://doi.org/10.1016/j.colsurfb.2016.07.039
  26. Perminova et al. (2005) Springer https://doi.org/10.1007/1-4020-3252-8
  27. Rimoli et al. (2008) Synthetic zeolites as a new tool for drug delivery (pp. 156-164) https://doi.org/10.1002/jbm.a.31763
  28. Sağir et al. (2016) Preparation and in vitro evaluation of 5-flourouracil loaded magnetite–zeolite nanocomposite (5-FU-MZNC) for cancer drug delivery applications (pp. 182-190) https://doi.org/10.1016/j.biopha.2015.12.025
  29. Sanders (1990) Drug delivery systems and routes of administration of peptide and protein drugs (pp. 95-102) https://doi.org/10.1007/BF03190192
  30. Santos et al. (2009) Calcium phosphate granules for use as a 5-fluorouracil delivery system (pp. 1587-1594) https://doi.org/10.1016/j.ceramint.2008.08.015
  31. Sathupunya et al. (2004) Microwave-assisted preparation of zeolite K–H from alumatrane and silatrane (pp. 157-164) https://doi.org/10.1016/j.micromeso.2004.02.003
  32. Spanakis et al. (2014) Controlled release of 5-fluorouracil from microporous zeolites (pp. 197-205) https://doi.org/10.1016/j.nano.2013.06.016
  33. Thabrew et al. (1997) Screening of hepatoprotective plant components using a HepG2 cell cytotoxicity assay (pp. 1132-1135) https://doi.org/10.1111/j.2042-7158.1997.tb06055.x
  34. Thom et al. (2003) The hemolytic and cytotoxic properties of a zeolite-containing root filling material in vitro (pp. 101-108) https://doi.org/10.1067/moe.2003.90
  35. Thomassen et al. (2012) Investigation of the cytotoxicity of nanozeolites A and Y (pp. 472-485) https://doi.org/10.3109/17435390.2011.587901
  36. Vellaian Karuppiah and Manavalan (2012) In-vitro and simulated in vivo dissolution of dipyridamole extended release capsules
  37. Vilaça et al. (2013) Potentiation of 5-fluorouracil encapsulated in zeolites as drug delivery systems for in vitro models of colorectal carcinoma (pp. 237-244) https://doi.org/10.1016/j.colsurfb.2013.07.042
  38. Wenande et al. (2017) Fractional laser-assisted topical delivery leads to enhanced, accelerated and deeper cutaneous 5-fluorouracil uptake (pp. 307-317) https://doi.org/10.1080/17425247.2017.1260119
  39. Wilkin and Barnes (1998) Solubility and stability of zeolites in aqueous solution: I. Analcime, Na-, and K-clinoptilolite (pp. 746-761) https://doi.org/10.2138/am-1998-7-807
  40. Winocur et al. (2006) The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice (pp. 66-75) https://doi.org/10.1016/j.pbb.2006.07.010
  41. Youssef et al. (2008) Microwave-assisted versus conventional synthesis of zeolite A from metakaolinite (pp. 527-534) https://doi.org/10.1016/j.micromeso.2008.02.030